| pubmed-article:2854714 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2854714 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:2854714 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:2854714 | pubmed:dateCreated | 1989-6-13 | lld:pubmed |
| pubmed-article:2854714 | pubmed:abstractText | The results of plasma perfusion through immunoabsorbent columns were assessed in neuroimmunological conditions. The method is a modified plasmapheresis. The plasma is passed through a column of polyvinyl alcohol gel bound with phenylalanine. Three patients were treated by this method (two with acute polyneuropathies due to the Guillain-Barré syndrome, and the third with a polyneuropathy related to Hepatitis A). Each patient underwent 3 sessions, on alternate days for a six day period, with perfusion of 6-6.5 1 of plasma. No adverse effects were observed during treatment or changes in PAO values. Serum Na+-K+-Cl-Ca++-Gluc-Tot Prot-Alb-RBC-WBC-Hb-Urea and Creatinine were constant. Complete remission of the peripheral symptoms of the patients with the Guillain-Barré syndrome was observed whilst the third patient had a partial remission (in the left arm). These observations suggest that this method may be of therapeutic value in patients with acute polyneuropathy due to the Guillain-Barré syndrome. | lld:pubmed |
| pubmed-article:2854714 | pubmed:language | fre | lld:pubmed |
| pubmed-article:2854714 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2854714 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2854714 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2854714 | pubmed:issn | 0003-410X | lld:pubmed |
| pubmed-article:2854714 | pubmed:author | pubmed-author:SerenaMM | lld:pubmed |
| pubmed-article:2854714 | pubmed:author | pubmed-author:Da PortoAA | lld:pubmed |
| pubmed-article:2854714 | pubmed:author | pubmed-author:CusumanoSS | lld:pubmed |
| pubmed-article:2854714 | pubmed:author | pubmed-author:MarescaM CMC | lld:pubmed |
| pubmed-article:2854714 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2854714 | pubmed:volume | 139 Suppl 1 | lld:pubmed |
| pubmed-article:2854714 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2854714 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2854714 | pubmed:pagination | 69-71 | lld:pubmed |
| pubmed-article:2854714 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2854714 | pubmed:meshHeading | pubmed-meshheading:2854714-... | lld:pubmed |
| pubmed-article:2854714 | pubmed:meshHeading | pubmed-meshheading:2854714-... | lld:pubmed |
| pubmed-article:2854714 | pubmed:meshHeading | pubmed-meshheading:2854714-... | lld:pubmed |
| pubmed-article:2854714 | pubmed:meshHeading | pubmed-meshheading:2854714-... | lld:pubmed |
| pubmed-article:2854714 | pubmed:meshHeading | pubmed-meshheading:2854714-... | lld:pubmed |
| pubmed-article:2854714 | pubmed:meshHeading | pubmed-meshheading:2854714-... | lld:pubmed |
| pubmed-article:2854714 | pubmed:meshHeading | pubmed-meshheading:2854714-... | lld:pubmed |
| pubmed-article:2854714 | pubmed:meshHeading | pubmed-meshheading:2854714-... | lld:pubmed |
| pubmed-article:2854714 | pubmed:meshHeading | pubmed-meshheading:2854714-... | lld:pubmed |
| pubmed-article:2854714 | pubmed:meshHeading | pubmed-meshheading:2854714-... | lld:pubmed |
| pubmed-article:2854714 | pubmed:meshHeading | pubmed-meshheading:2854714-... | lld:pubmed |
| pubmed-article:2854714 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:2854714 | pubmed:articleTitle | [Clinical use of IM-PH immuno-columns]. | lld:pubmed |
| pubmed-article:2854714 | pubmed:affiliation | Services de Néphrologie et de Neurologie, Hôpital de Trévise, Italie. | lld:pubmed |
| pubmed-article:2854714 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2854714 | pubmed:publicationType | English Abstract | lld:pubmed |
